EP3651723A1

EP3651723A1 - Sunscreen with a protection against textile spotting due to 4-(tert-butyl)-4´-methoxydibenzoylmethane

Info

Publication number: EP3651723A1
Application number: EP18738243.7A
Authority: EP
Inventors: Shimoda Toshihiko; Janina ZIPPEL; Andreas Bleckmann; Doreen Gutzke; Kathrin Reske
Original assignee: Beiersdorf AG
Current assignee: Beiersdorf AG
Priority date: 2017-07-13
Filing date: 2018-06-29
Publication date: 2020-05-20
Also published as: US20210085581A1; DE102017212014A1; WO2019011669A1

Abstract

The present invention relates to a cosmetic preparation containing 4-(tert-butyl)-4'-methoxydibenzoylmethane which is encapsulated with cellulose acetate, and to methods and uses of 4-(tert-butyl)-4'-methoxydibenzoylmethane which is encapsulated with cellulose acetate.

Description

description

Sunscreens protected by textile staining by 4- (tert-butyl) -4'-methoxydibenzoylmethane

The present invention relates to a cosmetic preparation containing 4- (tert-butyl) -4'-methoxydibenzoylmethane which is encapsulated with cellulose acetate, and to methods and uses of 4- (tert-butyl) -4'-methoxydibenzoylmethane which are reacted with cellulose acetate is encapsulated.

The trend away from the noble paleness to the "healthy, sporty brown skin" has been unbroken for years, to achieve this, people are putting their skin on the skin

Solar radiation, as this causes a pigmentation in the sense of melanin formation. However, the ultraviolet radiation of sunlight also has a damaging effect on the skin. In addition to the acute injury (sunburn), long-term damage such as an increased risk of developing skin cancer occurs due to excessive exposure to light from the UVB range (wavelength: 280-320 nm). The excessive action of UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous

phototoxic and photoallergic reactions and leads to premature aging of the skin.

To protect the skin, therefore, a number of sunscreen filter substances has been developed which can be used in cosmetic preparations. These UVA and UVB filters are in the form of positive lists in most industrialized countries such as Appendix 7 of the

Cosmetics Regulation summarized.

However, the large number of commercially available sunscreens must not disguise the fact that these prior art preparations contain a number of

Have disadvantages.

Cosmetic preparations, such as sunscreen preparations, which are applied to the skin, come regularly (intentionally or unintentionally) with garments and Laundry items (eg towels) in contact, where they (eg as "abrasion" or because they are "sucked" by the fibers) partially adhere. In this way, depending on the nature of the ingredients, especially on bright textiles stains and discoloration. These discolorations are particularly caused by non-water-soluble UVA and broadband filters such as 4- (tert-butyl) -4'-methoxydibenzoylmethane. The stains are difficult to remove by washing with conventional detergents and strengthen during the

Washing processes by interactions with ions of the wash water even more.

It was therefore the object of the present invention to eliminate the disadvantages of the prior art and to develop a cosmetic preparation (in particular a sunscreen) containing non-water-soluble UV-A filters such as 4- (tert-butyl) -4'-methoxydibenzoylmethane , which are easier from the contaminated with the preparation textiles

wash out. Surprisingly, the object is achieved by a cosmetic preparation containing 4- (tert-butyl) -4'-methoxydibenzoylmethane, which is encapsulated with cellulose acetate.

The object is further achieved by a process for facilitating the washability of 4- (tert-butyl) -4'-methoxydibenzoylmethane-containing cosmetic preparations of textiles, characterized in that the cosmetic preparation, the 4- (tert-butyl) -4 contains methoxydibenzoylmethane encapsulated in cellulose acetate.

The object is not least solved by the use of 4- (tert-butyl) -4'-methoxydiben- zoylmethan that is encapsulated with cellulose acetate, in cosmetic preparations to facilitate the washability of this UV-light filter from contaminated with the preparations textiles.

Although the prior art is familiar with polymethylmethacrylate (PMMA) encapsulated UV filters (e.g., DE102014206147, DE102014206156, DE102014206152), these references have not been found to pave the way for the present invention. In the context of the present disclosure, the formulations relate

"Inventive", "Preparation according to the invention" etc. are always based on the preparations, processes and uses according to the invention, i. also to preparations in which the uses according to the invention are realized as well as preparations with which the inventive method is realized.

The cellulose-encapsulated 4- (tert-butyl) -4'-methoxydibenzoylmethane according to the invention can be prepared, inter alia, analogously to Example 2 of WO2017 / 037716, using 4- (tert-butyl) -4'-methoxydibenzoylmethane instead of Titanium dioxides and Bismuthoxychlorides is used. Likewise, it can be prepared analogously to Example 2 of WO2014 / 133261 using cellulose acetate instead of the PMMA. The product can be obtained from Tagra Biotechnologies LTD, Netanya. It is advantageous according to the invention if the preparation according to the invention comprises one or more further UV filters selected from the group of the compounds hexyl 2- [4- (diethylamino) -2-hydroxybenzoyl] benzoate (INCI: diethylamino hydroxybenzoyl hexyl benzoate), 2-phenylbenzimidazole 5-sulfonic acid salts, 2,4,6-tris [anilino (p-carbo-2'-ethyl-1 '-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone), 2,4- Bis - {[4- (2-ethylhexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazines), 4,4 '- [[6- [[4 - [[(1, 1-dimethylethyl) amino] carbonyl] phenyl] amino] -1, 3,5-triazine-2,4-diyl] diimino] bis, bis (2) ethylhexyl) benzoate (INCI: diethylhexyl butamido triazone), 2,4,6-tribiphenyl-4-yl-1,3,5-triazine (INChTris-biphenyl triazine), 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylate), 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI: homosalates), 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl ) -phenol), 2-Et hylhexyl-2-cyano-3,3-diphenyl-acrylate, 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl- 1- [(trimethylsilyl) oxy] -1-disiloxanyl] propyl] phenol (INCI: drometrizole trisiloxane), [(3Z) -3 - [[4 - [(Z) - [7,7-dimethyl-2-oxo] 1- (sulfomethyl) -3-bicyclo [2.2.1] heptanylidenes] methyl] phenyl] methylidenes] - 7,7-dimethyl-2-oxo-1-bicyclo [2.2.1] heptanyl] methanesulfonic acid (INCI: terephthalylidene dicamphor sulfonic acid), merocyanines, titanium dioxide, zinc oxide.

These further UV filters can advantageously be used in individual concentrations of 0.1 to 10% by weight, based on the total weight of the preparation.

It is inventively preferred when the preparation of the invention is free of 2-hydroxy-4-methoxybenzophenone, 4-methoxycinnamic acid (2-ethylhexyl) ester 4-Methoxycinntsäu- reisoamylester and / or 3- (4-methylbenzylidene) camphor. Particular preference should be given to the use of 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isoamyl ester 3- (4-methylbenzylidene) camphor and 2-hydroxy-4-methoxybenzophenone.

In an alternative embodiment which is advantageous according to the invention, the preparation according to the invention is furthermore free of 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI:

Octocrylene).

It is advantageous for the purposes of the present invention, when the preparation of 4- (tert-butyl) - 4'-methoxydibenzoylmethane, which is encapsulated with cellulose acetate (ie the sum of 4- (tert-butyl) -4'-methoxydibenzoylmethan and cellulose acetate) in an amount of 0.1 to 10% by weight based on the total weight of the preparation.

The inventively preferred use concentration for this encapsulated 4- (tert-butyl) -4'-methoxydibenzoylmethane is from 0.5 to 7.5% by weight, based on the

Total weight of the preparation. The particularly preferred use concentration according to the invention for this encapsulated 4- (tert-butyl) -4'-methoxydibenzoylmethane is from 1 to 5% by weight, based on the total weight of the preparation.

The weight ratio of cellulose acetate to 4- (tert-butyl) -4'-methoxydibenzoylmethane in the capsules according to the invention is advantageously 20:80 to 60:40 and according to the invention preferably from 30:70 to 50:50 (cellulose acetate to 4- (tert. butyl) -4'-methoxydibenzoylmethane). It is advantageous according to the invention if the preparation according to the invention is in the form of an emulsion. In this case, it is preferred according to the invention if the preparation is in the form of an oil-in-water emulsion (O / W emulsion). According to the invention, the O / W emulsion is preferably in the form of a lotion.

If the preparation according to the invention is in the form of an emulsion, then the

According to the invention advantageous embodiments characterized in that the

Preparation glyceryl stearate citrate, cetearyl alcohol, sodium cetearyl sulfate, glyceryl stearate, cetearyl sulfosuccinate, sodium stearoyl glutamate, polyglyceryl-3-methyl glucose distearate,

Stearic acid, potassium cetyl phosphate, polyglyceryl-10 stearate (INCI polyglyceryl-10 stearates) and / or polyclyceryl-2 caprate.

These ingredients are advantageously used in individual concentrations of 0, 1 to 7% by weight, based on the total weight of the preparation.

It is inventively advantageous if the preparation of the invention is free of

Polyethylene glycol, polyethylene glycol ethers and polyethylene glycol esters (so-called PEG derivatives).

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation comprises ethylhexylglycerol, propylene glycol, butylene glycol, 2-methylpropane-1,3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol and / or 1 Contains 2-decanediol.

These compounds may be used alone or in combination in the invention

Preparation present. The use concentration according to the invention (individual concentration) for these ingredients is from 0.01 to 5% by weight, based on the total weight of the preparation.

In particular, the use of ethylhexylglycerol according to the invention is particularly advantageous. The advantageous use concentration according to the invention for ethylhexylglycerol is from 0.1 to 1% by weight, based on the total weight of the preparation.

It is advantageous according to the invention if the preparation according to the invention contains phenoxyethanol, 4-hydroxyacetophenone and / or ethanol. Phenoxyethanol can be used according to the invention advantageously in a concentration of 0, 1 to 0.9% by weight, based on the total weight of the preparation. According to the invention, 4-hydroxyacetophenone can advantageously be used in a concentration of 0.05 to 0.4% by weight, based on the total weight of the preparation.

According to the invention, ethanol can advantageously be used in a concentration of from 1 to 10% by weight, based on the total weight of the preparation.

Preferred according to the invention is the use of a combination of phenoxyethanol and

Ethylhexylglycerin.

Embodiments preferred according to the invention are obtained in that the

Preparation no parabens (especially propyl and Butylparaben), and no 3-iodo-2-propinylbutylcarbamat, methylisothiazolinone, chloromethylisothiazolinone and DMDM-hydantoin contains, so is free of these ingredients.

It is inventively advantageous if the preparation of the invention selected one or more of the perfume substances from the list of compounds limonene, citral, linalool, alpha-lsomethylionon, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert -Pentylcyclohexylacetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, adipic diester, alpha-amylcinnamaldehyde, alpha-methylionone, amyl C, butylphenylmethyl-propionalcinnamal, Amyl salicylate, amyl cinnamyl alcohol, aniseed alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenylmethylpropioal, cardamom oil, cedrol, cinnamal, cinnamyl alcohol, citronellylmethyl crotonate, citrus oil, coumarin, diethyl succinate, ethyllinalool, eugenol, ethylene brassylate, Evernia furfuracea extract, Evernia Prunastri extract, farnesol, guaiac wood, geraniol, hexylcinnamal, hexyl salicylate, hydroxycitronellal, hydroxyisohexyl 3-cyclohexene carboxaldehyde, lavender oil, lemone oil, linayl acetate, tangerine oil, menthyl PCA, methyl heptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation comprises one or more oils selected from the group of

Compounds butylenes glycol dicaprylate / dicaprate, phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropylsebacate, Dicaprylylcarbonate, Di-C12-13 Alkyl Tartrate, Butyloctyl Salicylate, Diethylhexyl Syringylidene Malonate, Hydragenated Castor Oil Dimerate, Triheptanoin, C12-13 alkyl lactates, C16-17 alkyl benzoates, propylheptyl caprylates,

Caprylic / capric triglycerides, diethylhexyl 2,6-naphthalates, octyldodecanol, caprylic / capric triglycerides, ethylhexyl cocoate.

These can be in single concentrations of 0, 1 to 15% by weight, based on the

Total weight of the preparation can be used.

Embodiments of the present invention which are advantageous according to the invention are also characterized in that the preparation comprises one or more compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, glycyrrhetinic acid, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A.

Embodiments of the present invention that are advantageous according to the invention are further characterized in that the preparation contains acrylate / C 10-30 alkyl acrylate crosspolymer and / or tricontanyl PVP.

Not least advantageous according to the invention is when the preparation according to the invention contains xanthan gum, tapioca starch and / or carboxymethyl cellulose.

It is also advantageous according to the invention if the preparation according to the invention comprises silica dimethyl silylates and / or talcum. The preparation of the invention may advantageously contain humectants. When

Humectants (moisturizers) are substances or mixtures of substances which give cosmetic preparations the property of reducing the moisture release of the horny layer (also called transepidermal water | oss (TEWL) after application or spreading on the skin surface) and / or hydrating the horny layer positively influence.

The aqueous phase of the preparations according to the invention may advantageously comprise conventional cosmetic auxiliaries, such as, for example, alcohols of low C number, preferably ethanol and / or isopropanol or polyols of low C number and their ethers, electrolytes, self-tanning agents and in particular one or more thickeners or which can be advantageously selected from the group of silica, aluminum silicates, polysaccharides or their derivatives, for. As hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose and / or polyacrylates (preferably a polyacrylate from the group of so-called carbopols, for example Carbopols types 980, 981, 1382, 2984, 5984, each individually or in combination).

Comparative tests / examples

The following comparative experiments / examples are intended to illustrate the present invention

clarify without restricting it. All amounts, proportions and percentages are, unless stated otherwise, based on the weight and the total amount or on the total weight of the preparations.

Example [%]

INCI

Bs .1 Bs 32 Bs p- 3 Bs 34 Example 5 Bsp.6 Bs D.7

Encapsula butyl

Ted M et h oxyd i bezoy I meth an 7.93 4.75 3.96 2.38 1.98 1.19 7.93 4.75

Avobenzone Cellulose Acetates 3.17 1.58 0.79 3.17

Cellulose acetate 5.00

Butyl M et h oxydi be nzoylmethane e 4.75 2.37 3.56 4.75 4.75

Homos Alate 9.00 9.00 9.00 9.00 9.00 9.00 9.00

Elhylhexyl salicylates 4.75 4.75 4.75 4.75 4.75 4.75 4.75

Until Ethylhexyloxyphenol

ethoxyphenyl triazines 4.00 4.00 4.00 4.00 4.00 4.00 4.06

Ethylhexyl Tnazone 3.00 3.00 3.00 3.00 3.00 3.00 3.00

Titanium Dioxide (nano) 0.82 0.82 0.82 0.82 0.82 0.82 0.82

Silica 0.15 0.15 0.15 0.15 0.15 0.15 0.15

Qimethicones 0.04 0.04 0.04 0.04 0.04 0.04 0.04

Phenylbenzimidazole Sulfonic Acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00

Tocopheryl Acetate 0.06 0.06 0.06 0.06 0.06 0.06 0.06

Hydroxy ac et opti enone 0.40 0.40 0.40 0.40 0.40 0.40 0.40

Panthenol 1.05 1.05 1.05 1.05 1.05 1.05 1.05

Ethylhexylglycerol 0.30 0.30 0.30 0.30 0.30 0.30 0.30

C 12-15 Alkyl Benzoate 2.00 2.00 2.00 2.00 2.00 2.00 2.00

Butylene Glycol Qicaprylate / Dicaprate 2.00 2.00 2.00 2.00 2.00 2.00 2.00

C 18-38 Alkyl Hydroxystearoyl Stearate 1.00 1.00 1.00 1.00 1.00 1.00 1.00

Glyceryl Stearate 1.00 1.00 1.00 1.00 1.00 1.00 1.00

Sodium stearoyl glutamate 0.25 0.25 0.25 0.25 0.25 0.25 0.25

Silica Dimethyl Silylate 1.00 1.00 1.00 1.00 1.00 1.00 1.00

Triacontanyl PVP 1.00 1.00 1.00 1.00 1.00 1.00 1.00

Perfume q.s. 1?, L.s, i.s, 1?. ,, g, s, i.s ,.

Glycerine 8,60 8,60 8,60 8,60 8,60 8,60 8,60

Sodium hydroxides q-s. 1?., G, s, 1?., S; S, i.5, ..

Stearyl Alcohol 1.25 1.25 1.25 1.25 1.25 125. 1,

Acrylates / CIQ-30 Alkyl Acrylates 0.15 0.15 0.15 0.15 0.15 0.15 0.15

Xanthan gum 0.40 0.40 0.40 0.40 0.40 0.40 0.40

Tetras odi u m 1 mi n odi s ucc i nat e 0.75 0.75 0.75 0.75 0.75

Sod i u m Carbox methylc el 1 u 1 os e 0,50 0,50 0,50 0,50 0,50

Alco ol De nat. 5.00 5.00 5.00 5.00 5.00 5.00 5.00

Tri-sodium EDTA 0.20 0.20 0.20 0.20 0.20 0.20 0.20

Aqua id 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100

Gel reduction -db [%] vs base 1 basis -30 -22 -15 o 1 I

Gel reduction -db [%] vs base .2 - - - - ■ Base 2 -30

Claims

claims

Cosmetic preparation containing 4- (tert-butyl) -4'-methoxydibenzoylmethane which is encapsulated with cellulose acetate.

A process for facilitating the washability of 4- (tert-butyl) -4'-methoxydiben- zoylmethan containing cosmetic preparations from textiles, characterized in that the cosmetic preparation, the 4- (tert-butyl) -4'-methoxydiben- zoylmethan in cellulose acetate-encapsulated form.

Use of 4- (tert-butyl) -4'-methoxydibenzoylmethane encapsulated with cellulose acetate in cosmetic preparations to facilitate the washability of this UV protection filter from textiles contaminated with the formulations.

Cosmetic preparation, process or use according to one of the preceding claims, characterized in that the preparation one or more further UV filters selected from the group of compounds hexyl 2- [4- (diethylamino) -2-hydroxybenzoyl] benzoate (INCI: Diethylamino hydroxybenzoyl hexyl benzoate), 2-phenylbenzimidazole-5-sulfonic acid salts, 2,4,6-tris [anilino (p-carbo-2'-ethyl-1 '-hexyl-oxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone),

2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,

3,5-triazine (INCI: bis-ethylhexyloxyphenol

methoxyphenyl triazines), 4,

4 '- [[6 - [[4 - [[(1, 1-dimethylethyl) amino] carbonyl] phenyl] amino] -1,3,

5-triazine-2,4-diyl] diimino] bis, bis (2-ethylhexyl) benzoate (INCI: diethylhexyl butamido triazone), 2,4,

6-Tribiphenyl-4-yl-1,3,5-triazine (INCI: tris-biphenyl triazine), 2-ethylhexyl 2-hydroxybenzoate (INCI: ethylhexyl salicylate), 3,3,5-trimethylcyclohexyl 2-hydroxybenzoate (INCI: Homosalates), 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol), 2-ethylhexyl-2-cyano- 3,3-diphenylacrylate, 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] -1-disiloxanyl] propyl] phenol (INCI: drometrizole trisiloxane), [(3Z) -3 - [[4 - [(Z) - [7,7-dimethyl-2-oxo-1- (sulfomethyl) -3- bicyclo [2.2.1] heptanylidenes] methyl] phenyl] methylidene] -7,

7-dimethyl-2-oxo-1-bicyclo [2.2.1] heptanyl] methanesulfonic acid (INCI: Terephthalylidene dicamphor sulfonic acid), merocyanines, titanium dioxide, zinc oxide.

Cosmetic preparation, process or use according to any one of the preceding claims, characterized in that the preparation comprises 4- (tert-butyl) -4'-methoxydibenzoylmethane encapsulated with cellulose acetate in an amount of 1 to 5% by weight the total weight of the preparation.

Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation is in the form of an emulsion.

Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation glyceryl stearate citrate, cetearyl alcohol, sodium cetearyl sulfate, glyceryl stearate, cetearyl sulfosuccinate Sodium stearoylglutamate, polyglyceryl-3-methylglucose distearate, polyglyceryl-3-methylglucose distearate, stearic acid, potassium cetyl phosphate, polyglyceryl-10 stearate (INCI polyglyceryl-10 stearates) and / or polyclyceryl-2 caprate.

8. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation Ethylhexylglycerin,

Propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol and / or 1, 2-decanediol.

9. Cosmetic preparation, method or use according to one of the preceding claims, characterized in that the preparation contains phenoxyethanol, 4-hydroxyacetophenone and / or ethanol.

10. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation of one or more of the perfume selected from the list of compounds limonene, citral, linalool, alpha-isomethylionone, geraniol, citronellol, 2-isobutyl-4 -hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexylacetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,1,4,4,6-hexamethyltetralin, adipic diester, alpha-amylcinnamaldehyde, alpha Methyl ionone, amyl C, butylphenyl methyl propionalcinnamal, amyl salicylate, amyl cinnamyl alcohol, anisalcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenyl methylpropioal, cardamom oil, cedrole, cinnamal, cinnamyl alcohol, citronellylmethyl crotonate, citrus oil, coumarin,

Diethyl succinate, ethyllinalool, eugenol, ethylene brassylate, Evernia furfuracea extract, Evernia prunastri extract, farnesol, guaiac wood oil, geraniol, hexyl cinnamal,

Hexyl salicylate, hydroxycitronellal, hydroxyisohexyl 3-cyclohexene carboxaldehyde, lavender oil, lemone oil, linayl acetate, tangerine oil, menthyl PCA, methylheptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin.

1 1. Cosmetic preparation, method or use according to one of

preceding claims, characterized in that the preparation is free of parabens, methylisothiazolinone, chloromethylisothiazolinone, 3-iodo-2-propynylbutylcarbamate, DMDM-hydantoin, 2-hydroxy-4-methoxybenzophenone, 4-

2-ethylhexyl methoxycinnamate, 4-methoxycinnamic acid isoamyl ester, 3- (4-methylbenzylidene) camphor.

12. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation one or more oils selected from the group of compounds butylene glycol dicaprylate / dicaprate,

Phenethyl benzoate, C12-15 alkyl benzoate, dibutyl adipate; Diisopropylsebacate,

Dicaprylyl carbonate, di-C12-13 alkyl tartrate, butyl octyl salicylate, diethylhexyl

Syringylidene Malonates, Hydragenated Castor Oil Dimerate, Triheptanoin, C12-13 Alkyl Lactates, C16-17 alkyl benzoates, propylheptyl caprylates, caprylic / capric triglycerides, diethylhexyl 2,6-naphthalates, octyldodecanol, caprylic / capric triglycerides, ethylhexyl cocoate.

13. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation one or more

Compounds selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine,

Glycyrrhetinic acid, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, magnolol, honokiol, tocopheryl acetate,

dihydroxyacetone; 8-hexadecene-1, 16-dicarboxylic acid, glycerylglycose, (2-

Hydroxyethyl) urea, vitamin E or its derivatives, hyaluronic acid and / or salts thereof and / or licochalcone A contains.

14. A cosmetic preparation, method or use according to any one of the preceding claims, characterized in that the preparation contains acrylate / C 10-30 alkyl acrylate crosspolymer and / or tricontanyl PVP.

Cosmetic preparation, process or use according to one of the preceding claims, characterized in that the preparation contains xanthan gum,

Tapioca starch and / or carboxymethyl cellulose contains.